#ESMO21 Expert Video Report on immunotherapy in gastro-oesophageal cancer

#ESMO21 Expert Video Report on Prostate cancerПодробнее

#ESMO21 Expert Video Report on NETsПодробнее

Expert Video Report on immunotherapy in gastro oesophageal cancer from 2021 ASCO Annual MeetingПодробнее

#ESMO21 Expert Video Report on colorectal cancerПодробнее

#ESMO21 Highlights on adagrasib in patients with KRASG12C-mutated CRC: The KRYSTAL-1 studyПодробнее

ESMO 2020 Expert Video Report on 1st line ICI for gastro oesophageal cancerПодробнее

Gastroesophageal Cancer: Current Positioning of ImmunotherapyПодробнее

Immunotherapy: esophageal and gastric cancerПодробнее

Immunotherapy for Gastroesophageal CancerПодробнее

Exploring Immunotherapy in Patients With Esophageal CancerПодробнее

Expert report on neoadjuvant immune checkpoint inhibitors for NSCLCПодробнее

Emerging data with immunotherapy in esophageal squamous cell carcinomaПодробнее

Navigating Multidisciplinary Care With Immunotherapy in Esophageal/GEJ CancerПодробнее

#ESMO21 Highlights on nivo+ipi vs EXTREME in 1st-line high-risk SCCHN: The CheckMate 651 studyПодробнее

Expert Video Report on therapeutic advances in NSCLC from 2021 ASCO Annual MeetingПодробнее